Quo vadis? The clinical dilemma of simultaneous cytomegalovirus infection and steroid-resistant rejection.
van den Berg
A P
AP
Division of Clinical Immunology, University Hospital Groningen, The Netherlands.
Tegzess
A M
AM
Scholten-Sampson
A
A
van der Giessen
M
M
The
T H
TH
van Son
W J
WJ
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000956:Antigens, Viral / Q000032:analysis; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000209:etiology* / Q000517:prevention & control; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects / Q000276:immunology; D008297:Male; D008775:Methylprednisolone / Q000494:pharmacology*; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D000956:Antigens, Viral; D000961:Antilymphocyte Serum; D015774:Ganciclovir; D008775:Methylprednisolone